These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28738266)

  • 1. ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation.
    Bidwell LC; Karoly HC; Hutchison KE; Bryan AD
    Drug Alcohol Depend; 2017 Oct; 179():18-24. PubMed ID: 28738266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD symptoms and smoking outcomes in a randomized controlled trial of varenicline for adolescent and young adult tobacco cessation.
    Green R; Baker NL; Ferguson PL; Hashemi D; Gray KM
    Drug Alcohol Depend; 2023 Mar; 244():109798. PubMed ID: 36774808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.
    Covey LS; Manubay J; Jiang H; Nortick M; Palumbo D
    Nicotine Tob Res; 2008 Dec; 10(12):1717-25. PubMed ID: 19023824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.
    Liebrenz M; Fisher CE; Nellen R; Frei A; Biechl AC; Hiestand N; Huber A; Buadze A; Eich D
    BMC Psychiatry; 2016 Jul; 16():208. PubMed ID: 27377376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
    Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
    JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
    Dunn KE; Marcus TF; Kim C; Schroeder JR; Vandrey R; Umbricht A
    Nicotine Tob Res; 2016 May; 18(5):1171-9. PubMed ID: 26476459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.
    Littlewood RA; Claus ED; Wilcox CE; Mickey J; Arenella PB; Bryan AD; Hutchison KE
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3417-3429. PubMed ID: 28889258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation.
    Gray KM; Upadhyaya HP
    CNS Drugs; 2009 Aug; 23(8):661-8. PubMed ID: 19594195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
    Peng AR; Schnoll R; Hawk LW; Cinciripini P; George TP; Lerman C; Tyndale RF
    Drug Alcohol Depend; 2018 Sep; 190():72-81. PubMed ID: 29986268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.
    Berlin I; Hu MC; Covey LS; Winhusen T
    Drug Alcohol Depend; 2012 Aug; 124(3):268-73. PubMed ID: 22364776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.
    Schuster RM; Cather C; Pachas GN; Zhang H; Cieslak KM; Hoeppner SS; Schoenfeld D; Evins AE
    Addict Behav; 2017 Aug; 71():89-95. PubMed ID: 28285208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of varenicline on subjective craving and relative reinforcing value of cigarettes.
    Green R; Ray LA
    Drug Alcohol Depend; 2018 Jul; 188():53-59. PubMed ID: 29751347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Varenicline on smoking cessation in a group of young asthma patients.
    Westergaard CG; Porsbjerg C; Backer V
    Respir Med; 2015 Nov; 109(11):1416-22. PubMed ID: 26427627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.
    McClernon FJ; Van Voorhees EE; English J; Hallyburton M; Holdaway A; Kollins SH
    Nicotine Tob Res; 2011 Sep; 13(9):784-92. PubMed ID: 21571687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program.
    Ikonomidis I; Marinou M; Vlastos D; Kourea K; Andreadou I; Liarakos N; Triantafyllidi H; Pavlidis G; Tsougos E; Parissis J; Lekakis J
    Atherosclerosis; 2017 Jul; 262():123-130. PubMed ID: 28549278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.
    Kollins SH; English JS; Roley ME; O'Brien B; Blair J; Lane SD; McClernon FJ
    Psychopharmacology (Berl); 2013 May; 227(1):19-30. PubMed ID: 23247366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.